Page 6
scienc
TECHN
lU rsday, March 8,
Thursday, Ma
THE BATTALION
House votes to pay expenses
for living organ donations
"j. WASHINGTON (AP) — Hoping
toencourage living Americans to do
nate a kidney or even a section of liv
er, the House voted unanimously on
Wednesday to help pay donors’ trav
el and other expenses.
' Living donations doubled during
the 1990s as medical techniques im
proved and the demand for organs
became more acute, while donations
after death grew very slowly.
“It’s a very simple, direct kind of
program. If you’re willing to help
and you’re willing to donate, we’re
going to help you,” said Rep. Karen
Thurman, D-Fla.
The legislation, approved 404-0,
with 31 members absent, also pro
vides for grants to states to try to in
crease donations after death.
The debate and vote were in stark
contrast to the last time the House
considered the issue of organ dona
tion, when lawmakers were sharply
divided over how available organs
should be distributed.
Most members supported the cur
rent system, which gives preference
to patients in the local areas; others
argued that organs should be offered
to the sickest patients first, even if
they live outside the area.
That debate is largely on hold for
now, and much of the attention has
turned to donation, where there is
more consensus. The legislation ap
proved Wednesday pulled out the
noncontroversial aspects of the 1999
House bill.
The legislation authorizes $5 mil
lion per year for grants to states and
organ banks to reimburse travel and
We want people to
be heroes, but we
don't want them to
be martyrs."
— Arthur Caplan
director of Center for Bioethics
at the University of Pennsylvania
other expenses for certain living
donors. It also allows for $ 15 million
for grants that would help states de
velop registries of people who wish
to donate and for public education
about donation. That money still
must be appropriated through the an
nual budget process.
Health and Human Services Sec
retary Tommy Thompson, who has
promised to offer his own program
promoting organ donation, said in a
letter that the Bush administration
supports the legislation.
It now heads to the Senate, where
Sen. Richard Durbin, D-Ill., is work
ing on a similar bill that would put
more emphasis on encouraging
donor registries.
Federal law prohibits paying for
organs, and an effort in Pennsylvania
to reimburse donor families for their
funeral expenses was scuttled amid
legal concerns about the payments.
The House bill takes a similar ap
proach, and both efforts represent
small steps toward paying for organs,
said Arthur Caplan, director of the
Center for Bioethics at the Universi
ty of Pennsylvania. But both are eth
ically sound, he said.
“We should all be concerned that
we not slide for paying for expenses
to just paying people for their parts,”
he said. But he said there is nothing
wrong with helping people who make
this choice on their own. “We want
people to be heroes, but we don’t want
them to be martyrs,” Caplan said.
While some contend government
should pay for organs, given their in
credible value, Caplan and others
worry that could erode support for
donation and create situations in
which people are pressured to donate
against their wishes.
More than 74,000 people await
transplants, and more than 6,100 die
each year waiting. The number wait
ing and the number of deaths have
each more than tripled since 1990.
Most donations come from peo
ple who have died. But in 1999, there
were 4,712 living organ donors.
Most of them donated one of their
two kidneys, though donations of a
piece of liver are becoming more
common, with 218dn 1999.
Only one kidney is needed for
normal function, and the two pieces
of a divided liver can each regener
ate to become full livers. Under the
national transplant network’s rules,
kidney donors who see their remain
ing kidney fail are given preference
on the waiting list.
Of the living donors, most are
family members, principally sib
lings. Twenty percent came from
people unrelated to the recipient in
1999.
The bill would allow states to pay
donors for travel and subsistence ex
penses if the donor and the recipient
live in different states and if the recip
ient has surgery at the closest trans
plant center. Those who donate organs
to patients with annual incomes over
$35,000 would not be eligible.
NT
Aspirin may redueomn*
ovarian cancer r
NASHVILLE, Tenn. (AP) —
Women who take aspirin at least
three times a week for an extended
period may decrease their risk of
ovarian cancer by as much as 40
percent, a new study shows.
The study’s findings parallel
previous studies on the preventative
powers of aspirin for heart disease
and cancers that begin in the colon
or rectum.
Women should realize that long
term use carries risks, including ul
cers-, says the lead author, Dr. Arslan
Akhmedkhanov of New York Uni
versity School of Medicine.
The study, funded by the Na
tional Institutes of Health and re
leased Wednesday at the annual
meeting of the Society of Gyneco
logic Oncologists, suggests that
regular aspirin use for at least six
months reduces the risk of epithe
lial ovarian cancer.
Epithelial ovarian cancer, the
most common ovarian cancer, orig
inates in the cells that cover the sur
face of a woman’s ovary.
Akhmedkhanov said his team’s
research could affect the treatment
and prevention of gynecologic
cancers but that more research is
needed.
He studied aspirin — an anti-in
flammatory — because chronic in
flammation could be related to ep-
wuje Brown
'Battalion
If was a nig
women’s
ithelial ovarian cancer, asiti owever, it was
dometriosis and pelvic intf: ere hoping fo
ry disease. odores blitzed
The study involved748« Hie loss drc
enrolled in the New YorkL; id ends the 2
ty Women s Health Study# atcli win streal
swered questions about thrive first top-10;
use from 1994 to 1996. Oftl &m, improve
developed epithelial ovarian mjwith their
Among the cancer pane mjjUd Stanforc
percent had used aspirin rep “Talent-wist
Anion- the rest. 16percer;, elhvith lhcm
ed regular aspirin use. is Coach Bobb
I he researcher said L eat X n a lot of g<
accountings for variables# hv hpn °
contraceptive use and fani; ^ '
cer history, he calculated t: uickl on ^
ular aspirin use could redi T
risk of developing the cancer? 0 - 01 ’ Ul11 "'
lajorie Terbui
PC, The study was the fifth* f^to Vandei
lationship between ovarian' , 1
and aspirin or other md Tsoobaoos *
anti-inflammatory drugs. . an 0 c
khanov said his was thefin:^ 0lbur ^ ’■
gin with*healthy participant'
were followed over time, a res
method considered more act.
than a retrospective study.
Akhmedkhanov’s study i
triguing, said Dr.
DuBois, director forgastroetj
<n! Vanderbilt lhiiversityyl
ical Center in Nashville,wt::
researched aspirin's relation# tv Jason Lingo
colon cancer. H
Aggi
inBi
he Battalion
The Texas Ai
California red-legged frog
gets habitat designation
FRESNO, Calif. (AP) — Celebrated for its jumping and protected for
its scarcity, the California red-legged frog has won a critical habitat des
ignation on more than 4 million acres of the state.
But the protection does not cover the county where Mark Twain set “The
Celebrated Jumping Frog of Calaveras County,” the classic 1865 short sto
ry about a frog that could “get over more ground in one straddle than any
animal of his breed you ever see.”
The irony was not lost on federal officials who approved the final 4.1-
ifrillion acre plan Tuesday.
“We hope to work with many people in Calaveras County who have ex
pressed to us they would like to have Mark Twain’s frog come home,” said
Patricia Foulk of the U.S. Fish and Wildlife Service.
, - The frog already was listed as “threatened,” but the new designation by
the Fish and Wildlife Service exposes developers to greater federal scruti
ny by mapping out where frog populations live or could recover.
The government had to develop the habitat plan after environmental groups
successfully sued, claiming the government had to declare a critical habitat
for any species protected under the Endangered Species Act. The amphibians
are considered an important indicator species of the health of aquatic areas.
The frogs once numbered in the millions in California but now only
four places are known to have populations greater than 350, said Peter
Galvin, a conservation biologist for the Center for Biological Diversity.
Africans may save on AIDS drug
wn fell by sev
nFeb. 17 in Co
have to reve
ler to keep its se
he Phillips 66 E
I The 11 th-see
Merck pharmaceutical manufacturer to sell medications for zero
■L J J L J '.onference tour
by-case basis, Reaves said. equivalent Sustiva costs $4,730 per patier:|emper Arena
Reaves said the company is looking in particu- year, will be sold for $500 a year. ■The Big 1
lar at “those countries where clearly the disease is Merck said the treatments will beavailafetys an excitii
most devastating, and also where economic con
ditions are devastating.”
Merck, one of the world’s biggest manufactur
ers of AIDS drugs, makes Crixivan and Stocrin,
TRENTON, N.J. (AP) — Pharmaceutical man
ufacturer Merck & Co. announced that it will dras
tically cut prices for two HIV drugs in AIDS-rav
aged Africa and other developing parts of the world.
In a statement Wednesday, the company said it
will make no profit when selling the two protease-
inhibitor drugs in developing countries. The drugs
will be made available at about one-tenth of their
U.S. price.
Merck and other drug companies have come
under sharp criticism from various governments
and relief groups, which accuse them of keeping
patented lifesaving medicines beyond the reach of
the world’s poor.
“The reason we did this is we’re trying to speed
the process of access to these medicines,” said
Merck spokesman Greg Reaves. “We thought it
would now spur other entities to get involved.”
More than 25 million of the 36 million peo
ple infected with HIV live in sub-Saharan Africa,
one of the world’s most impoverished regions.
Developing countries in other areas will be eval
uated for the reduced-price program on a case-
u
We thought it would
now spur other entities to
get involved”
reduced price to governments, relief agenc: nvolved,” s
others who can provide them to patients, Alelvin Watkii
condition that the drugs be used only in the. to say it’s
tries where they are sold. Ip that’s true.
Protease inhibitors, introduced in record ar
1990s, revolutionized AIDS treatment, t”"' 1 ^ NCAA tou
ing the disease from a death sentence into ai
“That’s wha
ageable chronic ailment for many patients, bat
drugs typically are mixed with two other,5plv ia , ve a nc
medicines such as AZT and 3TC. ■ The A S8 ICS
— Greg Reaves
Merck spokesman
Officials with Doctors Without Bottol^toura
which suppress HIV levels in the body and can be
used alone or in drug combinations known as
AIDS cocktails.
Crixivan, which sells for $6,016 per patient per
year in the United States, will be sold in develop
ing countries for $600 a year; Stocrin, whose U.S.
Nobel Peace Prize-winning relief agency, four seas(1
corned Merck’s announcement but cautionecL urne a AM
the reduced price could still leave the drugs(. O f eac ^ ontest
reach for many of Africa’s AIDS patients. ^ ven straight o
“It’s also important that the person onthesJ|L es dating b
who is working, but whose employer isn’tp; B
for it, can go and get them,” said Toby Kasper, |
works for the agency just outside Cape It
South Africa.
LUNEUf™ Monthly Contraceptive Injection
medroxyprogesterone acetate and estradiol
cyplonate Injectable suspension
o/ lot] on to
Injection
Is
LUNELLE™ Monthly Contracept
(like all hormonal contraceptiv
intended to prevent pregnancy.
It does not protect against HIV Infection
(AIDS) and other sexually transmitted
• 0verage35andsmoke15ormore cigarettes
per day
Tell your health care provider if you have ever had
any of these conditions. Your health care provider
can recommend a safer method of birth control.
ABE.THERE OTHER THINGS TO CON-
MONTHLY CONTRACEPTIVE INJECTION?
For the majority ol women, hormonal contracep
tives can be taken safely. But there are some
GIRL’S SOFTBALL UMPIRES WANTED
Anyone interested in officiating girl's fast pitch soft
ball. Assignments are available Monday through
Saturday each week. Games are played from
February through November. Pay ranges from
$12.50 to $30.00 per game. Clinics, training, and
testing are provided for each official. For more
information call Mike Littlejohn at 776-5062, Terry
Mix at 693-2958 or Tony Scazzero at 778-0133.
ADULT SLOW-PITCH UMPIRES WANTED
Monday-Thursday 6:15-10:15 and weekends. Games
Feb. 19 - October. $8.00 to $ 12.00 per game. For
mgpe information call Mike Littlejohn at 776-5062
or Terry Hix at 693-2958.
This summary contains important Information
about LUNELLE 1 " Monthly Contraceptive
Injection. It is not meant to take the place of dis
cussions with your doctor and It cannot replace
your doctor’s advice. Only your doctor can assess
the benefits and risks to decide if LUNELLE™
Monthly Contraceptive Injection is right for you.
Talk to your doctor or pharmacist, or other pre
scribing healthcare professional, if you do not
understand any of lliis information or II you want
to know more about LUNELLE™ Monthly
Contraceptive Injection.
WHAT IS LUNEUE™JllQNffllX£QXIRA:
CEPTWEINJECTION?
LUNELLE™ Monthly Contraceptive Injection is a
lype of hormonal birth control that is given as an
injection (a shot) in your arm, thigh, or buttock
liver tumors can rupture and cause fatal internal of death Is always lower than that associated with ier or lighter, and there may be no bleeding, fewer 2. While breast feeding
bleeding. In addition, a possible but not definite pregnancy lor any age group, although over (he days ol bleeding, or more days of bleeding than if you are breast feedino consult your health
association has been found with hormonal contra- age ot 40, the risk increases to 32 deaths per what you have previously experienced. Such T Drov j(j er he( 0re startino hormonal contraceo-
ceptives and liver cancSrs in Iwo studies, in which 100,000 women, compared to 28 associated with bleeding usually does not indicate any serious ^ iSno LUNRI F" 9 MonSv ^
a tew women who developed these very rare can- pregnancy at that age. However, lor oral hormonal problems. II an altered bleeding pattern persists or COTt'rarStaiOT&xrrdtttedruasinhor-
cers were found to have used hormonal contra- contraceptive users who smoke and are over the the bleeding is severe, discuss it with your health on totte (Jttfoin
ceptives lor long periods. However, liver cancers age ot 35, the estimated number ol deaths care provider. There is also a small risk that ™ are ^ on ™ ™ in
are extremely rare. The chance of developing liver exceeds those for other methods of birth control, (painful) cramps may be associated with bleeding,
cancer from using hormonal contraceptives is thus If a woman is over the age ot 40 and smokes, 2. Weight change
even rarer. ■ her estimatKl risk of death is four times higher Weight gain is a common side effect in women
women who are at high risk of developing certain 4, Cancer of the reproductive organs and (117/100,000 women) than Ihe estimated risk
serious diseases that can be life-threatening or breasts
may cause temporary or permanent disability. Tell There is, at present, no confirmed evidence that in that age group.
(n /yiuu.uuu women) than Ihe estimated risk usinn LUNELLE™ Monthlv Cnnlramiiivp
associated with pregnancy (28/100,000 women) injection. The average exp«ctS wight ^iii
lin is 4
breast milk. A few adverse effects on the child
have been reported, including yellowing of the
skin (jaundice) and breast enlargement. In addi
tion, hormonal contraceptives may decrease the
amount and quality of your milk, to insure ihe
tgf N milk, you
your health care provider If you have:
• Breast nodules, Fibrocystic disease of the
breast, an abnormal breast x-ray or mammo-
8 ram, strong family history of breast cancer
iabetes
• Elevated cholesterol or triglycerides
• High blood pressure
• Migraine or other headaches or epilepsy
• Mental depression
Gallbladder, heart or kidney disease
pounds in Ihe first year of use. Some women gain should wail until 6 weeks after childbirth before
oral hormonalcontraceptives increase Ihe risk of An Mvisory Committee of the FDA discussed Jbis more than 10 to 20 pounds in the first year. you start using LUNELLE™ Monthly Contraoeplive
ies. Studies to date of women taking Ihe pill have of oral contraceptive use by healthy, non-smoking lost as much as 48 pounds in one year ol use ceptives while breast feeding
«||| —|| iw n|''"““‘"h the Clinical trials showed wide variability in individual Breast feeding provides only partial protection
, KISH ftS'?! ^ 'hcreasmg percentage ol from becoming pregnant and this padial protec-
LUNELLE Monlhly Contraceptive Injection users tion decreases significantly as you breast teed for
experiencing weight change in excess of 10 and longer periods of time. You should use another
continued treatment. method of contr
20 pounds with
3. Contact lenses
It you wear contact tenses and notice a change in
vision or an inability to wear your lenses, contact
your doctor or health care provider.
4. Fluid retention
3 use the lowest dose oral contracep-
pill use have found no overall increase in the risk live that is effective, and are strongly advised not
ot developing breast cancer, although some stud- to smoke.
ies have reported an increased risk of developing WHAT SYMPTOMS MAY SIGNAL PR0B-
breast cancer in certain groups of women. LEMS WHILE USING LUNELLE™ 1 M0NTH-
• History ot scanty or irregular menstrual periods Some studies have found an increase in the inci- LY CONTRACEPTIVE INJECTION?
• Smoke, especially it 35 years or older dence ot cancer ot the cervix in women who use Call your doctor immediately it any ol these
Women with any of these conditions should be oral hormonal contraceptives. However, this find- adverse effects occur while you are laking
checked often by their health care provider if they ing may be related to factors other than the use of LUNELLE™ Monthly Contraceptive Injection, Hnmnnal mntrarwviw* m*,
once a monttrto prevent pregnancy. It contains ^ ^^ELLE™ Monthly Contraceptive oral hormonal contraceptives. • Sharp chest pain, coughing of blood, or sudden retention) with swellino of the linners nr ankips am
hormones which have effects similar to the natural Studies have found that women who used
homones estrogen and progesterone produced A|S0 - be sure ,0 lnlorm V our t™ 0 ! or ft®* injectable hormonal contraceptives (Depo-Provera
in your body. Similar combinations ot hormones Provider if you smoke or are on any medications. Contraceptive Injection) had no increased overall
are found in some oral contraceptives also known WHAT ARE THE RISKS ASSOCIATED WITH risk of developing cancer of the breast, ovary,
as "birth control pills" or Ihe pill," When you TAKING HORMONAL CONTRACEPTIVES? uterus, or cervix. However, women under 35 years
receive your injections once a month as pre- 1. Risk ot developing blood clots, heart of age whose first exposure to Depo-Provera
scribed, LUNELLE™ Monthly Contraceptive attacks, and strokes Contraceptive Injection was wiihm Ihe previous 4
Injection is as effective as birth control pills. When Blood clots and blockage of blood vessels are the 5 Y® 5 J^ve a slightly increased risk of
given according to the prescribed schedule, most serious side effects ot taking hormonal con- d®'*teP in Q ot®® 51 cancer similar to that seen with
LUNELLE" Monthly Contraceptive Injection is traceptives. In particular, blood clots can occur in oral contraceptives,
effective in preventing pregnancy during Ihe cycle the legs and can travel to the lungs and can cause Women who use hormonal contraceptives and
in which il is given. Clinical studies have shown sudden blocking of the vessel carrying blood to have a strong family history of breast cancer or
bharp chest pain, coughing ol blood, or sudden ^jon) ^ J™ 0 f the finoers or ankles and
“g)' “ (indica,ing 3 possible clot ^ KXraJ iyou experience
I of contraception while breast feeding and
consider starting hormonal contraceptives only
after you have weaned your child completely.
3. Laboratory tests
If you are scheduled for any laboratory tests, tell
your doctor you are taking a hormonal contracep
tive. Certain blood tests may be affected by hor
monal contraceptives.
4. Drug interactions
your menstrual bleeding.
Even il you do not have any menstrual bleed
ing, you should stiff return once a month for
your injection of LUNELLE™ Monlhly
Contraceptive Injection.
It is important lhal you receive each ol your next
injections ai the right time. If you cannot receive
your injection on lime, contact your health care
provider lo receive an earlier injection.
What Happens If I Miss an Injection or Watt
Longer than 33 Days Between Injections?
• You could become pregnant if you miss your
injection or wail longer than 33 days between
injections. The more days you wail, the greater
Ihe risk that you could become pregnant
• Ask your health care provider lo recommend
anolner type ot birth control (such as condoms
or a spermicide) for you to use.
• Talk with your health care provider lo find out
when you should receive your next injection of
LUNELLE™ Monlhly Contraceptive Injection.
• Your health care provider may do a lesl lo make
sure you are not pregnant before giving you
your next injection ol LUNELLE™ Monthly
Contraceptive Injection.
Pregnancy Due to Failure w/th LUNELLE™
Monthly Contraceptive Injection
The incidence ol failure with LUNELLE™ Monthly
Contraceptive Injection resulting in pregnancy is
Itein in foe calf (indicating a possible dot in the leg) U^^iion, Contact your doctor or heallh care teSl^Z'p»T/oO
Crushing chest pain or heaviness in the chest L nthur j 6 ?, wro^P®'year) if given every month as directed
possible heart attack) Kypu think trial you may .be pregnant be sure to
iindicating a possible stroke)
• Sudden partial or complete loss of vision
MAKE MONEY
THE
OLD-FASHIONED
WAY
SELL
SOMETHING.
The Battalion
Classifieds
Call 845-0569
that when women receive LUNELLE" Monlhly
Contraceptive Injection according to the recom
mended schedule, the failure rate of this method
of birth control is less than 1% per year.
WHO SHOULD NOT TAKE EUNEUE™
MONTHLY
ILY CONTRACEPTIVE INJECTION?
Cigarette smoking increases the risk of
serious cardiovascular side effects from
hormonal contraceptive use. This risk
Increases with age and with heavy smok-
a (15 or more cigarettes per day) and is
a marked in women over 35 years ol
age. Women who use hormonal contra
ceptives are strongly advised not to smoke.
the lungs. Rarely, clots occur in the blood vessels whohave breast nodules or abnormal mammo-
of the eye and may cause blindness, double
vision, or impaired vision.
If you take hormonal contraceptives such as
LUNELLE™ Monthly Contraceptive Injection and
need elective surgery, need to stay in bed tor a
prolonged illness, or have recently had a baby,
gram should be closely followed by their doctors.
5. Changes in bone mineral density
Use of injectable hormonal contraceptives con
taining Ihe progesterone-type hormone found in
LUNELLE™ Monthly Contraceptive Injection may
be associated with a decrease in the amount of
spverphrafbrhp m vnmit nn riimrvKc 0,,le, si<)e e,lec ts ^ include breast pain or ten- Such drugs include aminoglutethimide, rifampin,
or fainiino disturbances of vision or sneerh denless ' ^ chan 3 e in Wtite, nausea, headache, drugs used for epilepsy such as barbiturates (tor
weakness’or numbness in an arm nr ten C ’ nervousness, depression, mood changes, changes example, phenobarbital), carbamazepine, and
' n D ess 1 armoneg insexualdesire,dizziness, loss of scalp hair, rash, phenytoin (Dilantin is one brand of this drug),
and vaginal infeciions. If any of these side effects phenylbutazone (Butazolidin is one brand), Fierbal
bother you, caff your health care provider. products containing St. John’s Wort (hypericum
lumps hndlraiina'possibie'"Mast cancer WHAT PRECAUTIONS SH0ULP.QL perforatum), and possibly certain antibiotics. You
or fibrS K of Ibe b ^1 XS FOLLOWED OURING USE OF LUNELLE? may need lo use an additional contraception
alsKr"*” 5 " sssstsss.
Sfwrefainwienrtenessinineabdtmnal trawiffimbstoreordurin.pnjfliiaiicy
area (indicating a possibly ruptured liver tumor, You may not mgnstruate regularly after you LUNELLE™.Monlhly Contraceptive Injecti espec y if you tad i egular
ovarian cyst, or pregnancy outside the uterus) receive an injerjon of LUNELLE™ Monthly Sexually transmitted diseases
call your health care provider.
What III Want to Become Pregnant?
You will need lo stop your monlhly injections of
LUNELLE™ Monlhly Contraceptive Injedion. Most
women begin lo produce eggs again (and could
become pregnanl) about Iwo to Ihree months afct
their Iasi injection.
There may be some delay in becoming pregnant
before you started using
il contraceptives.
you may be at risk of developing blood clots. You mineral stored in your bones, ftiis could increase UCMICM|UI|;
Si * SM^q^nTiKaTgSL 5, receiving injectable contapiive's as scheduled is diseases such as chlamydia.genital her-
ct iitwu anti nru haVmn hnmvmai mnfrar'ontiuoQ iranftoisimnf mniranentive hi il after that of appetite, dark-colord urine, or light-colored very low, If you have not received your injections pes, genital warts, gonorrhea, hepatitis B,
bowel movements (indicating possible liver as scheduled and missed a menstrual period, or il and syphilis.
surgery and not taking hormonal contraceptives use of this lype of contraceptive, but after that, it
for two weeks after surgery or during bed rest. You begins to resemble the normal rate of age-related
should also not take hormonal contraceptives bone mineral loss,
soon after delivery of a baby. It is advisable lo wait 6. Allergic reactions
The risk of unexpected pregnancy for women HIV (AIDS) and other sexually transmitted
■I injectable con
WHATSHOULDIKNOWABOUTA
POSSIBLE QVERDQSE OF LUNELLE!"
Some women should not use hormonal contra-
for at least four weeks after deliv
hormonal contraceptives such as LUNELLE™
Severe allergic reactions have been reported in
some women using injectable hormonal contra-
' ehor-
problems) you missed two consecutive menstrual periods, 6. Weight change
• fosistent pain, pus, or bleeding at the injection site yon rnay be preflnant. Check with your health care LUNELLE™ Monthly Contraceptive Injection may
• Unusually heavy vaoinal bleedina provider immediately lo determine whether you cause weioW oain of more than 10 pounds.
b pregnant or think you may be pregnant.
" ' )t use LUNELLE™ Monthly
should also not i
Contraceptive Injection if you have any of the fol
lowing conditions:
' A history of heart attack or stroke
id clot
• Blood clots in Ihe legs (thrombophlebitis),
lungs (pulmonary embolism), or eyes
• A history of blood clots in the deep ve
your legs
• Chest pain (angina pectoris)
> Known or suspected breast cancer or cancer
USE OF LUNELLE MONTHLY CONTRACEPTIVE
INJECTION?)
Hormonal contraceptives may also increase the
y to develop strokes (stoppage or rupture
ceptives containing the progesterone-type
mone found in LUNELLE™ Monthly Contraceptive TiuFTiiciFTTinw?
Injection. Allergic reactions occurring in women i wJ n in5hiooIiinn
using LUNELLE™ Monthly Contraceptive Injection " a ' b ' " ,
Unusually heavy vaginal bleeding
WHAT ARE THE POSSIBLE SIDE EFFECTS
OF LUNELLE " MONTHLY CONTRACEP-
have"been mainly skin reactions, and not respira- Most 'women using LUNELLE™ Monthly
lory in nature. Serious allergic reactions require o l !fy erlel ^ allerallon of
.... . emergency medical treatrrwit. ? en ^ ll l leedln ? h , B tt 9 1 pa * e L , ^? ayv ? , >„
of blood vessels in the brain) and angina pectoris fshmatfd risk of ofath frrm a birth "On}, 3 .single monthly bleed to no bleeding at all
and heart attacks (blockage of blood vessels in the CONITOL MEffiOD OR PREGNANCY 111 2 r sll9ht stainin9 belwmi mens,rial pe,iods 10
veins of heart). Any of these conditions can cause death or All methods of birth control and
frequent, prolonged, and/or unpredictable bleed-
the lining ot the uterus, cervix or vagina
• Unexplained vaginal bleeding (until a diag
nosis Is reached by your doctor)
• Yellowing of the whites ot the eyes or of the
skin (jaundice) during pregnancy or during
previous use ot the pill or other hormonal
contraceptives
provider immediately lo determine whether you cause weight gain of more than 10 pounds,
are pregnant. Do not continue the injections until WHEN DO I GET MY LUNELLE™ 1 MONTH-
you are sure you are not pregnant, but use another [_y CONTRACEPTIVE INJECTION?
method ot contraception. LUNELLE 1 " Monthly Contraceptive Injection can
There is no conclusive evidence lhat oral hormonal only be effective if you receive your injections at
contraceptive use is associated with an increase in ihe proper times,
birth defects, when taken inadvertently during early ff/sf Injection
within the first 5 days of the start of your
normal menstrual period.
It you are presently using another type of birth
control, your heallh care provider will decide
the best time for you to start LUNELLE™
Monthly Conlraceptive Injection. This will help
make sure you have continued conlraceptive
coverage.
If you have recently been pregnant oi had a
effects have not been reported lolkmiiig
ingestion of large doses of oral horrnonal contraoepftes
by young childien. Ovendosage may cause nausea and
withdraval bleeding in temales. In case ol ovetdosage
conlacl your heallh care provider or pharmacist
Keep this and all drugs out of the reach ot children.
OTHEHJNFORMATIQN
Your heallh care provider will lake a medical
and family history before prescribing hormonal
conlraceplives. You should receive yearly physical
examinations by your heallh care provider. Be sure
to inform your health care provider if there is a
family history of any ol the conditions listed previ
ously in Ibis leaffet. Be sure to keep all appoint
ments with your health care provider, because Ibis
is a lime to determine if there are early signs ol
side effects ol hormonal contraceptive use. If you
• liver tumor (benign or cancerous)
• Known or suspected pregnancy
• Allergy to any of Die ingredients contained in
LUNELLE™ Monthly Contraceptive Injection
pregnancy. Nevertheless, hormonal contraceptives
should not be used during pregnancy.
With Depo-Provera Contraceptive Injection, there
have been reports of an increased risk of low birth
weight and neonatal infant death or other health
«asorKsasassss*- SaaaSSff s^aisassa.
KXsasKiss pstaffpissr
of developing and dying of heart disease, particu- Th e risk of death from anv birth control melhnrt is ln 42% of women durin9 lhe ,irsl monlh 01 use c . or | t,ace P ,lve Injection (MPA), and followed to
larlyil you are over 35 years of age. l^tatt^sko^^feeStfoSta- and in 29% of women at the end ot one year ol adolescence.showed no evidence of any adverse
2. Gallbladder disease irorKn^tiw^rs wlteMe of I who S ln , any 9lven in|f ? tion interval, approximately efe* on their health including their physical,
Hormonal contraceptive users probably have a smoke and oral hormonal contraceptive users al i and ' ° r 500131 devel0Dmfrt
greater risk than non-users ol having gallbladder over the age of 40 even if they do not smoke. For varh S mwr
ifunnumoa »r«*«wt>«isisar ssraz'KKlrSZ"" “-s
women. Your menstrual blood flow may be heav- tion taken during pregnancy. nu j 0 J 3 *? 51 ?*. your P revlou 1 s , iLwl monthly cotllraceplive in edlOfl
injection, and not by the liming or amount ol m<h*»|]nigKt8nmac8t®8^
want more information about hormonal contracep
tives, ask your health care provider or pharmacist
. „ . . . .. for a more technical leallet called the Prescribing
baby, discuss with your^heatth care provider the information that you may wish to read.
Rx only:
Manufactured by:
best time for you to start LUNELLE™ Monthly
Contraceptive Injection.
Acct 230
Econ 202
Dr. Alien
Econ 322
Einc 309
Math 142
Math 151
Math 152
Mgmt 211